ReP USP - Resultado da busca

Artigo de periodico
Mogamulizumab versus investigator's choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphoma (2019)
Phillips, Adrienne A; Fields, Paul A; Hermine, Olivier; Ramos, Juan C; Beltran, Brady E; Pereira, Juliana ; Wandroo, Farooq; Feldman, Tatyana; Taylor, Graham P; Sawas, Ahmed
Source: Haematologica. Unidade: FM
Subjects: ANTICORPOS MONOCLONAIS, LEUCEMIA, LINFOMA, LINFÓCITOS T, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PHILLIPS, Adrienne A et al. Mogamulizumab versus investigator's choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphoma. Haematologica, v. 104, n. 5, p. 993-1003, 2019Tradução . . Disponível em: https://doi.org/10.3324/haematol.2018.205096. Acesso em: 02 nov. 2024.
APA
Phillips, A. A., Fields, P. A., Hermine, O., Ramos, J. C., Beltran, B. E., Pereira, J., et al. (2019). Mogamulizumab versus investigator's choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphoma. Haematologica, 104( 5), 993-1003. doi:10.3324/haematol.2018.205096
NLM
Phillips AA, Fields PA, Hermine O, Ramos JC, Beltran BE, Pereira J, Wandroo F, Feldman T, Taylor GP, Sawas A. Mogamulizumab versus investigator's choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphoma [Internet]. Haematologica. 2019 ; 104( 5): 993-1003.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3324/haematol.2018.205096
Vancouver
Phillips AA, Fields PA, Hermine O, Ramos JC, Beltran BE, Pereira J, Wandroo F, Feldman T, Taylor GP, Sawas A. Mogamulizumab versus investigator's choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphoma [Internet]. Haematologica. 2019 ; 104( 5): 993-1003.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3324/haematol.2018.205096
Trabalho de evento-resumo periodico
Observational study of Switching anti-TNF agents in ankylosing spondylitis: effectiveness and predictors (2014)
Saad, C. G. S.; Shimabuco, A. Y.; Ribeiro, A. C. M.; Moraes, J. C. B.; Sampaio-Barros, P. D.; Goldenstein-Schainberg, C.; Gonçalves, C.; Bonfa, E.
Source: Clinical and Experimental Rheumatology. Conference titles: International Congress on Spondyloarthropathies. Unidade: FM
Subjects: LINFOTOXINA, ESPONDILITE ANQUILOSANTE, LINFÓCITOS T, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAAD, C. G. S. et al. Observational study of Switching anti-TNF agents in ankylosing spondylitis: effectiveness and predictors. Clinical and Experimental Rheumatology. Pisa: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.clinexprheumatol.org/article.asp?a=8723. Acesso em: 02 nov. 2024. , 2014
APA
Saad, C. G. S., Shimabuco, A. Y., Ribeiro, A. C. M., Moraes, J. C. B., Sampaio-Barros, P. D., Goldenstein-Schainberg, C., et al. (2014). Observational study of Switching anti-TNF agents in ankylosing spondylitis: effectiveness and predictors. Clinical and Experimental Rheumatology. Pisa: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.clinexprheumatol.org/article.asp?a=8723
NLM
Saad CGS, Shimabuco AY, Ribeiro ACM, Moraes JCB, Sampaio-Barros PD, Goldenstein-Schainberg C, Gonçalves C, Bonfa E. Observational study of Switching anti-TNF agents in ankylosing spondylitis: effectiveness and predictors [Internet]. Clinical and Experimental Rheumatology. 2014 ; 32( p. 833):[citado 2024 nov. 02 ] Available from: http://www.clinexprheumatol.org/article.asp?a=8723
Vancouver
Saad CGS, Shimabuco AY, Ribeiro ACM, Moraes JCB, Sampaio-Barros PD, Goldenstein-Schainberg C, Gonçalves C, Bonfa E. Observational study of Switching anti-TNF agents in ankylosing spondylitis: effectiveness and predictors [Internet]. Clinical and Experimental Rheumatology. 2014 ; 32( p. 833):[citado 2024 nov. 02 ] Available from: http://www.clinexprheumatol.org/article.asp?a=8723
Artigo de periodico
Lymphocyte subpopulations in patients with advanced breast cancer submitted to neoadjuvant chemotherapy (2000)
Murta, Eddie Fernando Candido; Andrade, Jurandyr Moreira de; Falcão, Roberto Passetto; Bighetti, Sérgio
Source: Tumori. Unidade: FMRP
Subjects: NEOPLASIAS MAMÁRIAS, QUIMIOTERAPIA, SISTEMA IMUNE, LINFÓCITOS T
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MURTA, Eddie Fernando Candido et al. Lymphocyte subpopulations in patients with advanced breast cancer submitted to neoadjuvant chemotherapy. Tumori, v. 86, n. 403-407, 2000Tradução . . Acesso em: 02 nov. 2024.
APA
Murta, E. F. C., Andrade, J. M. de, Falcão, R. P., & Bighetti, S. (2000). Lymphocyte subpopulations in patients with advanced breast cancer submitted to neoadjuvant chemotherapy. Tumori, 86( 403-407).
NLM
Murta EFC, Andrade JM de, Falcão RP, Bighetti S. Lymphocyte subpopulations in patients with advanced breast cancer submitted to neoadjuvant chemotherapy. Tumori. 2000 ; 86( 403-407):[citado 2024 nov. 02 ]
Vancouver
Murta EFC, Andrade JM de, Falcão RP, Bighetti S. Lymphocyte subpopulations in patients with advanced breast cancer submitted to neoadjuvant chemotherapy. Tumori. 2000 ; 86( 403-407):[citado 2024 nov. 02 ]

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em